iOS app Android app

John Horton
GET UPDATES FROM John Horton
 
John Horton is the President and founder of LegitScript, a service that verifies and monitors the online sale of pharmaceutical products. From 2002 until 2007, Mr. Horton served as a policy advisor in the drug policy office of The White House. In that capacity, he coordinated federal policy on a variety of issues, including prescription drug abuse and Internet pharmacies. From 1997 until 2002, Mr. Horton was a prosecutor in Multnomah County, Oregon. In 1999, he served as legal counsel to the Oregon House and Senate Judiciary Committees.

Entries by John Horton

If ICANN Doesn't Keep Registrars Honest, Who Will?

(3) Comments | Posted November 5, 2014 | 5:47 PM

Last week, The Wall Street Journal detailed the challenges that drug safety authorities like the FDA face when tackling the illegal and unsafe distribution of prescription medicines via the Internet. The WSJ analysis discussed role of the Internet Corporation for Assigned Names and Numbers (ICANN) as...

Read Post

Drug Shortages and You: Who's At Risk, What's the Fix?

(1) Comments | Posted March 9, 2012 | 2:00 PM

Imagine that you're a cancer patient. There's a highly effective drug for your condition, your doctor prescribes it, your health care covers it. Now the bad news: Even though it's approved by the U.S. FDA, it's out of stock at every pharmacy you call.

Apparently, you'll have to wait...

Read Post

Austerity Measures at the Expense of Our Health?

(2) Comments | Posted January 24, 2012 | 1:47 PM

America's system of government was designed by the founding fathers to be frustrating. During that time, the English King ran a tight ship: without internal checks on the monarch's power, things were efficient, but a bit unfair. Topping the U.S. colonials' list of grievances? Imposition of "taxes... without Consent," suspension...

Read Post

Medical Innovation and Shortening the Long Goodbye

(0) Comments | Posted December 21, 2011 | 2:05 PM

Seventeen years ago, Ronald Reagan penned what some have called his "Long Goodbye": a letter to the American people announcing that he had been diagnosed with Alzheimer's disease. He poignantly thanked readers for allowing him to serve as president. "I only wish there was some way I could spare Nancy...

Read Post

Child's Play: The PBM Merger That Can Learn From Childhood Lessons

(8) Comments | Posted December 2, 2011 | 9:56 AM

One of the central organizational principles in the US market -- indeed, in all modern Western, non-centralized economies -- is that competition is good for consumers. When market share is diffuse, and multiple businesses have to battle for the same customers, they have to offer the best price possible. All...

Read Post

Could a Pharmacy Monopoly Affect Your Healthcare?

(0) Comments | Posted October 31, 2011 | 5:35 PM

Teddy Roosevelt, our swashbuckling 26th U.S. President, is probably best-known for his love of the environment and post-presidential African hunting tours. But today, two of his lesser-known but lasting legacies -- antitrust law and ensuring that U.S. residents have access to safe medicines -- are about to intersect in ways...

Read Post

Web-Based Entities: A Crucial Tool for Affordable Health Care

(0) Comments | Posted September 27, 2011 | 12:52 PM

For minorities, those in lower-income brackets, and other populations who are underserved by the U.S. healthcare system, it's a double whammy: disproportionately affected by diseases like diabetes, these communities are often left to fend for themselves by a complex and not-easily-accessible healthcare system.

Changing our massive, complicated national healthcare...

Read Post

You're a Person, Not a Data Point

(1) Comments | Posted June 3, 2011 | 4:55 PM

"You've got high blood pressure," the doctor says, "but the good news is, we can manage it." As your physician discusses a prescription regimen, you're startled to learn that there are over 200 medications that can be used to help treat your hypertension. How are you -- and...

Read Post

Data Exclusivity: Getting the Balance Right

(0) Comments | Posted May 19, 2011 | 3:28 PM

Federal budgets are all about numbers -- typically, the type of numbers that are preceded by dollar signs. But other numbers in the Administration's 2012 budget limit something called "data exclusivity protection" for a type of drug called "biologics".

Sound dry and bureaucratic?...

Read Post

Facebook-MyWOT Crowdsourcing Deal: A Reminder the Internet Belongs to All

(0) Comments | Posted May 16, 2011 | 12:34 PM

Rubbing my eyes awake at 5 a.m. most mornings, the first thing I typically do is look at my iPhone and check my email and Facebook account. The other day, I was startled to see an angry and quite profane Facebook message from an old friend from high...

Read Post

Biosimilar and Counterfeit Meds: When Do They Become Dangerous?

(2) Comments | Posted March 31, 2011 | 8:25 AM

A recent 60 Minutes special blasted open the dark and dangerous world of counterfeit drugs -- a multi-billion dollar market that potentially affects the health and safety of anybody taking a prescription drug. The tens of thousands of fake prescription drugs that enter the U.S. each year range...

Read Post

Biologic Drugs: Biosimilars May Be Cheaper, But Are They Safe?

(3) Comments | Posted December 14, 2010 | 7:06 AM

Where there's medicine, there's money.

That statement should come as no surprise to anyone who has ever looked at a medical bill or filled a prescription: Pharmaceuticals alone are a more than $800-billion market ($300 billion of that is in the United States alone).

But the statement has an...

Read Post

Biologics: Are Unsafe Drugs an 'Acceptable Risk?' FDA Should Say 'No!'

(67) Comments | Posted November 7, 2010 | 10:19 AM

For cancer patients, what is the "acceptable risk" that a drug will pose safety risks or won't work properly? That's one of the thorny questions addressed by the FDA last week in a two-day, open-to-the-public meeting about "biosimilar" drugs -- second-generation versions of drugs made from living organisms, or "biologics."

Read Post

When Drug Companies Choose Profits Over People

(5) Comments | Posted September 29, 2010 | 2:18 PM

For medication safety, we rely on our doctors to prescribe and our pharmacists to dispense the right drugs. But on whom do doctors and pharmacists rely? Increasingly, the answer is drug companies. This is not inherently bad. After all, a drug company probably knows its product better than anyone, and...

Read Post

Unapproved Drugs Mixed With HIV Medications Can be a Risky Prescription

(0) Comments | Posted September 8, 2010 | 12:11 PM

Earlier this year, the Food and Drug Administration (FDA) added an arrow to proverbial medical quivers in the ongoing war on HIV and AIDS: updated warnings on interactions between HIV-medications and non-HIV drugs. The warnings specify that some drugs, when used in combination with HIV medications, may dilute the HIV...

Read Post

Drugs Should Meet 2010 Standards for Drug Safety

(4) Comments | Posted August 18, 2010 | 3:36 PM

Benjamin Franklin, from his own experience, warned: "Be temperate in wine and eating, or the Gout will seize you." Were he alive today, he might append a cautionary note: "But in treating it, make sure that the medicine is FDA-approved."

Such wisdom might have saved the lives of three Oregon...

Read Post